M
Motoaki Shichiri
Researcher at Kumamoto University
Publications - 142
Citations - 10127
Motoaki Shichiri is an academic researcher from Kumamoto University. The author has contributed to research in topics: Insulin & Diabetes mellitus. The author has an hindex of 47, co-authored 142 publications receiving 9892 citations.
Papers
More filters
Journal ArticleDOI
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.
Yasuo Ohkubo,Hideki Kishikawa,Eiichi Araki,Takao Miyata,S. Isami,S. Motoyoshi,Yujiro Kojima,Naohiko Furuyoshi,Motoaki Shichiri +8 more
TL;DR: In conclusion, intensive glycemic control by multiple insulin injection therapy can delay the onset and the progression of diabetic retinopathy, nephropathy and neuropathy in Japanese patients with NIDDM.
Journal Article
Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
TL;DR: Intensive glycemic control can delay the onset and progression of the early stages of diabetic microvascular complications in Japanese patients with type 2 diabetes.
Journal ArticleDOI
Telemetry Glucose Monitoring Device With Needle-Type Glucose Sensor: A Useful Tool for Blood Glucose Monitoring in Diabetic Individuals
TL;DR: Continuous glucose monitoring of five diabetic subjects for 77 ± 22 h revealed that a significant correlation existed between the subcutaneous tissue glucose concentration and the plasma glucose concentration measured simultaneously in each patient.
Journal ArticleDOI
Long-Term Clinical Effects of Epalrestat, an Aldose Reductase Inhibitor, on Diabetic Peripheral Neuropathy: The 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial
Nigishi Hotta,Yasuo Akanuma,Ryuzo Kawamori,Kempei Matsuoka,Yoshitomo Oka,Motoaki Shichiri,Takayoshi Toyota,Mitsuyoshi Nakashima,Isao Yoshimura,Nobuo Sakamoto,Yukio Shigeta +10 more
TL;DR: Long-term treatment with epalrestat is well tolerated and can effectively delay the progression of diabetic neuropathy and ameliorate the associated symptoms of the disease, particularly in subjects with good glycemic control and limited microangiopathy.
Journal Article
In vivo characteristics of needle-type glucose sensor--measurements of subcutaneous glucose concentrations in human volunteers.
TL;DR: In vivo monitoring was conducted in human subjects and a good linear relationship was observed between the tissue and plasma glucose concentrations, indicating the clinical usefulness of the needle-type glucose sensor.